GIONCO DAVID (Chief Accounting Officer) sold 3.4% of their position (8.56K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $103.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/27/2019ACC: 0001104659-19-011258
Officer· Chief Accounting Officer
Since Feb 2019
-8.56K
Net shares
Net seller
$103.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.56K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.56K
Price / share
$12.03
Trade value
$103.01K
% of position
3.4%
2/25/2019
248.90K→240.34K
Total
Net shares
−8.56K
Net value
-$103.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/25/2019 | S · Sale | −8.56K | $12.03 | $103.01K | 3.4% | 248.90K | 240.34K |
| Total | −8.56K | -$103.01K | ||||||
Derivative Transactions0
No derivative transactions reported